Kramer was the CEO of Emergent BioSolutions, a government contractor hired to mass produce coronavirus vaccine doses, 400 ...

Robert Kramer, former CEO of Emergent BioSolutions, allegedly earned more than $10.1 million by executing trades with ...

New York's attorney general has filed an insider trading lawsuit against former Emergent BioSolutions CEO Robert Kramer, ...

New York Attorney General sued the former CEO of Emergent BioSolutions, Robert G. Kramer, for insider trading.

Letitia James accused Robert Kramer of selling his shares in Emergent before disclosing contamination issues in its ...

Robert G. Kramer sold nearly 90,000 shares of his stock in Emergent BioSolutions, knowing that large quantities of vaccine ...

A former biotech CEO pocketed more than $10 million by selling company stock after learning of serious COVID-19 vaccine ...

Former Emergent BioSolutions Inc. CEO Robert Kramer engaged in illegal insider trading during the Covid-19 pandemic, ...

More than 3,000 prescriptions were written for Novo’s GLP-1 pill in its first week on the market. Elsewhere, Emergent reached ...

Emergent BioSolutions, Inc. (NYSE: EBS) shares plunged Monday. The Gaithersburg, Md.-based company announced it made a ...

The New York attorney general’s office has filed suit against the former CEO of Emergent Biosolutions Inc., alleging insider trading, while at the same time announcing a settlement with the company, ...